Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: Correlative study of AZD9496 oral SERD phase I trial Meeting Abstract
| Authors: | Cani, A. K.; Dolce, E. M.; Darga, E. P.; Hu, K.; Brown, M.; Liu, C. J.; Pierce, J.; Bradbury, K.; Aung, K.; Schiavon, G.; Carroll, D.; Carr, T. H.; Klinowska, T.; Lindemann, J.; Marshall, G.; Rowlands, V.; Harrington, E. A.; Barrett, J.; Armstrong, A.; Baird, R.; Hamilton, E.; Im, S. A.; Jhaveri, K.; Patel, M. R.; Dive, C.; Tomlins, S. A.; Udager, A. M.; Hayes, D. F.; Paoletti, C. |
| Abstract Title: | Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: Correlative study of AZD9496 oral SERD phase I trial |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263507371 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-3143 |
| Notes: | Meeting Abstract: 3143 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
